Microbiology and Immunology
Add to your Conference/Group
Add your comments:
Insert YouTube Videos inside your Slideworld presentation Copy and paste the video URL from YouTube, choose where to insert the video, and press “Submit”. The video will play in your slideshow after sometime.
Enter YouTube video URL
Enter Slide No where you want to insert youtube videos
Post a comment
Post Comment on Twitter
Post Comment on SlideWorld
Subscribe to follow-up comments
SlideWorld will not store your password. SlideWorld will maintain your privacy.
Subscribe to follow-up comments
, favourited this 1 Years ago.
Slide 1 :
Program Coordinator: Laura Kasman, Ph.D. kasmanL@musc.edu
Slide 2 :
M&I program currently 17 Ph.D. students 4 MD/Ph.D. students 1 DMD/Ph.D. student 2 Masters students 15 Departmental faculty 40 Total Program faculty
Slide 3 :
Program Requirements 6 credits in advanced M&I courses in 2nd year Written qualifying exam, summer after 2nd year Thesis proposal defense, usually sometime in 3rd year for admission to candidacy 12 advanced credits total, not including M&I Seminar
Slide 4 :
M&I Advanced course offerings
Slide 5 :
Departmental vs. Program Faculty Department Faculty have M&I as their home department M&I Program Faculty can be faculty members from any MUSC department that have research interests related to microbiology or immunology Faculty can be affiliated with more than one graduate program
Slide 6 :
M&I Department Faculty Interests
Slide 7 :
Bacteriologists Michael Schmidt Hal May Ed Balish
Slide 8 :
Virologists Natalie Sutkowski John Y. Dong Laura Kasman
Slide 9 :
Immunologists Janardan Stephen Gabriel Aziz Carl Pandey Tomlinson Virella Haque Atkinson Also Natalie Sutkowski
Slide 10 :
Tumor Immunologists & Gene Therapy James Norris Christina Xiang Liu Semyon Voelkel-Johnson Rubinchik Also Stephen Tomlinson & John Dong
Slide 11 :
Program Faculty Surgery Prabhakar Baliga Mike Nishimura Kenneth Chavin David Cole Yi Zhang Pathology Amanda LaRue Otolaryngology Rita Young Neurosciences/Neurology Narendra Banik Narayan Bhat James Cook William Tyor Swapan Ray Pediatrics Inderjit Singh Isabel Virella-Lowell
Slide 12 :
Program Faculty College of Dental Medicine Robert Boackle Caroline Westwater Radiation Oncology Sebastiano Gattoni-Celli College of Pharmaceutical Sciences Craig Beeson Cell Biology & Anatomy Titus Reaves Rheumatology James Oates Maria Trojanowska Gary Gilkeson Biochemistry Greg Warr Maurizio Del Poeta Division of Infectious Disease Christopher Parsons
Slide 13 :
Entrepreneurship by M&I faculty
Slide 14 :
MOUNT PLEASANT, SC (AUGUST 30, 2007) - Groundbreaking ceremony for new facility at Innovation Park, in the economic development zone of The Market at Oakland. GenPhar, Inc. is a biopharmaceutical company dedicated to providing vaccines that protect against infectious diseases with great socio-economic impacts worldwide. Biodefense programs: GenPhar's vaccine platform is ideally designed for biodefense because one vaccine can prevent infection from multiple virus subtypes.
Slide 15 :
James S. Norris, PhD Co-Founder, SphingoGene, Inc. http://www.sphingogene.com Professor and Chairman, MUSC email@example.com SphingoGene, Inc. SphingoGene, Inc. is focused on commercialization of small molecule therapeutics that modify ceramide metabolism to overcome resistance to chemo and radiation therapy and promote apoptosis in cancer cells. Ceramide is a “tumor suppressor sphingolipid” involved in regulation of cell death. SphingoGene, Inc.’s molecules are rationally designed and proven to inhibit enzymes that create resistance to conventional cancer therapies. Our goal is to utilize these small molecules in combination with “standard of care” radiation or chemotherapy to enhance cancer cell death. Commercial Lipidomic Services Molecular diagnostic to predict patient Response Combination therapy for standard of care Therapies in cancer patients (chemo, radiation and gene therapy Products and Services
Slide 16 :
Controlling Inflammation to Treat Human Disease Applying novel technologies to create better treatments Contact: Woodruff Emlen MD firstname.lastname@example.org Taligen Therapeutics, Inc. is a development stage biotechnology company with novel technology to modulate and regulate activation of the complement system. Inappropriate complement activation leading to inflammation is a major contributor to a large number of human diseases. Taligen has proof of concept data in animal models of diseases as diverse as asthma, macular degeneration, immune renal disease, inflammatory arthritis, ischemia-reperfusion injury, stroke and traumatic brain injury. Product Development Currently focused on the areas of asthma and age related macular degeneration. Stephen Tomlinson, PhD Professor email@example.com
Slide 17 :
Dr. Hal May, Ph.D. VP, MFC Technologies LLC http://www.mfctech.net firstname.lastname@example.org Assoc. Prof. MUSC email@example.com Microbially Generated Electricity Increase Biofuel Production 24/7 Remote Power, Sensor Control Control Waste, Odor and Algae
Slide 18 :
MFC Tech is focused on the development of microbial fuel cell technology (MFCs), which utilizes the ability of bacteria to generate electricity. Patentable approaches are targeted for the enhancement of waste management and electricity generation, namely… 24/7 remote power generation such as along highways and in retention ponds Development of specific sensors or the powering of sensors in remote locations Enhancement of biofuel production through the application of MFC technology to cellulosic ethanol fermentation The reduction of agricultural waste, odors and algal blooms in waste lagoons and retention ponds
The Immunology of Fi...
Principles of Immuno...
Immunology and immun...
Automation in Microb...
Free Powerpoint Templates
4 Years ago.
4753 Views, 1 favourite
Otolaryngology. Rita Young. Neurosciences/Neurology. Narendra Banik; Narayan Bhat; James Cook; Will
Otolaryngology. Rita Young. Neurosciences/Neurology. Narendra Banik; Narayan Bhat; James Cook; William Tyor; Swapan Ray. Pediatrics …academicdepartments.musc.edu/immunology/education/Information/ForPoster.ppt
More By User
Flag as inappropriate
Select your reason for flagging this presentation as inappropriate. If needed, use the
form to let us know more details.
Other Terms Of Service Violation